https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
Low TT ( 142.39ng/dL) was a risk factor for both the composite outcome and for death alone within 90days. Multivariate analysis revealed TT to be an independent predictor for the composite outcome (hazard ratio 2.57, 95% CI 1.09-6.02; P = 0.03. Low serum testosterone is common among male patients with HBV-ACLF and predictive of increased severity and worse outcome of the disease and may play an important role in the progression of HBV-ACLF. Low serum testosterone is common among male patients with HBV-ACLF and predict
Like
Comment
Share
